Cite
PSS14 REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE.
MLA
Kaplan, D., et al. “Pss14 Real-World Costs in Biologic-Naive Psoriasis Patients Initiating Apremilast or Biologics in a Us Healthcare Claims Database.” Value in Health, vol. 22, Nov. 2019, p. S888. EBSCOhost, https://doi.org/10.1016/j.jval.2019.04.1778.
APA
Kaplan, D., Ung, B., Pelletier, C., Udeze, C., & Tian, M. (2019). Pss14 Real-World Costs in Biologic-Naive Psoriasis Patients Initiating Apremilast or Biologics in a Us Healthcare Claims Database. Value in Health, 22, S888. https://doi.org/10.1016/j.jval.2019.04.1778
Chicago
Kaplan, D., B. Ung, C. Pelletier, C. Udeze, and M. Tian. 2019. “Pss14 Real-World Costs in Biologic-Naive Psoriasis Patients Initiating Apremilast or Biologics in a Us Healthcare Claims Database.” Value in Health 22 (November): S888. doi:10.1016/j.jval.2019.04.1778.